|
NCOA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.84480053034531E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.05029999644779E-08 |
| Normal-vs-Stage2 |
1.31969999994652E-06 |
| Normal-vs-Stage3 |
8.59500248751033E-11 |
| Normal-vs-Stage4 |
4.65789995462984E-09 |
| Stage1-vs-Stage2 |
5.100400E-01 |
| Stage1-vs-Stage3 |
5.815800E-02 |
| Stage1-vs-Stage4 |
9.802000E-02 |
| Stage2-vs-Stage3 |
4.771600E-01 |
| Stage2-vs-Stage4 |
4.152400E-01 |
| Stage3-vs-Stage4 |
8.066600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.85740003774993E-09 |
| Normal-vs-AfricanAmerican |
6.45959999999723E-05 |
| Normal-vs-Asian |
3.53210000000326E-05 |
| Caucasian-vs-AfricanAmerican |
8.995400E-01 |
| Caucasian-vs-Asian |
2.509800E-01 |
| AfricanAmerican-vs-Asian |
4.043200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32560004587157E-09 |
| Normal-vs-Female |
7.08180003528014E-09 |
| Male-vs-Female |
5.697600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.22660000045904E-07 |
| Normal-vs-Age(41-60Yrs) |
9.85670001174554E-09 |
| Normal-vs-Age(61-80Yrs) |
8.40400005142072E-09 |
| Normal-vs-Age(81-100Yrs) |
1.562560E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.068200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.672300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.039200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.955200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.579600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.885000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.305020E-01 |
| Classical-VS-Follicular |
3.362300E-03 |
| Classical-VS-Other |
8.903600E-02 |
| Classical-VS-Normal |
1.03169999987607E-07 |
| Tall-VS-Follicular |
3.671000E-01 |
| Tall-VS-Other |
3.493600E-01 |
| Tall-VS-Normal |
8.85940000028285E-07 |
| Follicular-VS-Other |
7.627800E-01 |
| Follicular-VS-Normal |
1.70000002963633E-09 |
| Other-VS-Normal |
5.637000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83649984109024E-10 |
| Normal-vs-N1 |
4.64400000010912E-07 |
| N0-vs-N1 |
7.131000E-01 |
|
|
